BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19160098)

  • 1. The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment.
    Falanga A
    Cancer Invest; 2009 Jan; 27(1):105-15. PubMed ID: 19160098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate thromboprophylaxis in hospitalized cancer patients.
    Amin A; Stemkowski S; Lin J; Yang G
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):910-20. PubMed ID: 19209141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    White RH; Chew H; Wun T
    Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in cancer patients undergoing major surgery.
    Osborne NH; Wakefield TW; Henke PK
    Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer in males and risk of venous thromboembolism.
    Beyer-Westendorf J; Werth S; Halbritter K; Weiss N
    Thromb Res; 2010 Apr; 125 Suppl 2():S155-9. PubMed ID: 20433997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for cancer-associated venous thromboembolism.
    Connolly GC; Khorana AA
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Place of cancer among the risk factors in venous thromboembolism].
    Descourt R; Righini M; Carrier M; Le Gal G
    Pathol Biol (Paris); 2008 Jun; 56(4):178-83. PubMed ID: 18325691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
    Connolly GC; Khorana AA
    Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism in the cancer surgical patient.
    Kakkar AK
    J Clin Oncol; 2009 Oct; 27(29):4881-4. PubMed ID: 19738112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying cancer patients at risk for venous thromboembolism.
    Sousou T; Khorana A
    Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboprophylaxis during chemotherapy after advanced cancer.
    Agnelli G; Verso M
    Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T; White RH
    Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
    Laporte S; Mismetti P
    Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer patients and awareness of venous thromboembolism.
    Sousou T; Khorana AA
    Cancer Invest; 2010 Jan; 28(1):44-5. PubMed ID: 20001296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.